Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected Patients

Trial Profile

Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2015

At a glance

  • Drugs Efavirenz (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 25 Aug 2015 Last checked against ClinicalTrials.gov record
    • 03 Dec 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 02 Jan 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top